Marshall

  • Marshall posted an update 8 months, 3 weeks ago

    e associated with a low bleeding risk. Our data support consideration of a 2-4 week trial of antithrombotic therapy, usually starting with antiplatelet therapy, in aPL-positive patients with refractory migraine, particularly if other treatment options have been exhausted. As a retrospective study, our data provide only Class IV level of e…[Read more]

  • Marshall posted an update 8 months, 4 weeks ago

    Although benzophenone-3 seemed protective on low-fat diet, spindle cell tumors arising in these mice showed increased proliferation and decreased apoptosis. This points to a need for further studies of benzophenone-3 in both animal models and humans as a potential breast cancer risk factor, as well as a more general need to evaluate endocrine…[Read more]

  • Marshall posted an update 9 months, 1 week ago

    Approximately 30% of patients experience nausea after initiation of opioid therapy, which can lead to poor quality of life. We aimed to identify risk factors for opioid-induced nausea at the initiation of opioid therapy by conducting a retrospective review of medical records of patients diagnosed by palliative care specialists with solid cancer…[Read more]

  • Marshall posted an update 9 months, 1 week ago

    Please see http//www.annualreviews.org/page/journal/pubdates for revised estimates.Purpose This study aims to explore the physical, psychological and social wellbeing of veterans who have experienced limb-loss and to ascertain the factors that contribute to the ability of veterans to maintain their independence at various stages in their…[Read more]

  • Marshall became a registered member 9 months, 1 week ago

Skip to toolbar